There are also hypothetical problems with using epinephrine in large transplant sessions. One is that when the drug is infiltrated into the scalp over large areas, it may predispose to post-operative telogen effluvium (shedding). Another, potentially more serious problem, is that when adrenaline is added to an area whose blood supply is already compromised by a large number of recipient sites, the tissue may not receive enough oxygen. Although not proven, it is likely that epinephrine infiltration into the recipient area is a contributing factor in the development of the “central necrosis” that has occasionally been reported during hair transplantation. It is also possible that the intense vasoconstrictive action of epinephrine may contribute to decreased graft survival.
Either way if you get a transplant in a particular zone then future treatments could be used on the rest of the head, and a second pass of a transplant could provide enough density where you intially had work. I'm hoping the rest of the head will not be affected
11-12-2010 09:15 AM
KeepTheHair
I honestly have no idea what you are talking about lol
I hope not...because then I could perhaps get a hair transplant next year and still get histogen when it comes out or so.
11-12-2010 09:24 AM
thejack
Haha sorry
Epinephrine is used in combination with the anesthetic to increase the duration of it's action. Also reduces how much anesthetic is needed to be used.
I doubt it would affect the scalp in the longterm though, but I really don't know
11-12-2010 09:38 AM
KeepTheHair
It would really suck to get a "ok" hair transplant and then be unable to benefit from a cure if it comes out lol...that would be very bad
11-12-2010 10:29 AM
level
Quote:
Originally Posted by KeepTheHair
It would really suck to get a "ok" hair transplant and then be unable to benefit from a cure if it comes out lol...that would be very bad
Yeah, dude-I agree! Hopefully some experts can chime in on this!
11-12-2010 01:53 PM
gillenator
This is something best answered by a licensed physician.